Literature DB >> 36262557

Treatment of Ischemic Stroke Following Intracranial Hemorrhage in a Patient with Continuous Flow Left Ventricular Assist Device: Between a Rock and a Hard Place.

Hee Jeong Lee1, Yun Seok Kim2, Woo Sung Jang2, Keun Tae Kim3, Chang-Hyun Kim4, In-Cheol Kim1.   

Abstract

Entities:  

Year:  2021        PMID: 36262557      PMCID: PMC9536686          DOI: 10.36628/ijhf.2021.0034

Source DB:  PubMed          Journal:  Int J Heart Fail        ISSN: 2636-154X


× No keyword cloud information.
  4 in total

1.  Outcomes after stroke complicating left ventricular assist device.

Authors:  Joshua Z Willey; Michael V Gavalas; Pauline N Trinh; Melana Yuzefpolskaya; A Reshad Garan; Allison P Levin; Koji Takeda; Hiroo Takayama; Justin Fried; Yoshifumi Naka; Veli K Topkara; Paolo C Colombo
Journal:  J Heart Lung Transplant       Date:  2016-03-30       Impact factor: 10.247

2.  INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.

Authors:  Deepak Acharya; Renzo Loyaga-Rendon; Charity J Morgan; Kara A Sands; Salpy V Pamboukian; Indranee Rajapreyar; William L Holman; James K Kirklin; José A Tallaj
Journal:  JACC Heart Fail       Date:  2017-10       Impact factor: 12.035

3.  Stroke after implantation of continuous flow left ventricular assist devices.

Authors:  Athanasios Tsiouris; Ioannis Heliopoulos; Dimitrios Mikroulis; Panayiotis D Mitsias
Journal:  J Card Surg       Date:  2019-05-21       Impact factor: 1.620

4.  The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.

Authors:  Jeffrey J Teuteberg; Mark S Slaughter; Joseph G Rogers; Edwin C McGee; Francis D Pagani; Robert Gordon; Eduardo Rame; Michael Acker; Robert L Kormos; Christopher Salerno; Thomas P Schleeter; Daniel J Goldstein; Julia Shin; Randall C Starling; Thomas Wozniak; Adnan S Malik; Scott Silvestry; Gregory A Ewald; Ulrich P Jorde; Yoshifumi Naka; Emma Birks; Kevin B Najarian; David R Hathaway; Keith D Aaronson
Journal:  JACC Heart Fail       Date:  2015-10       Impact factor: 12.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.